Skip to main content
. 2023 Oct 19;13:17898. doi: 10.1038/s41598-023-45195-z

Figure 4.

Figure 4

Viremia and antibody responses association with fatality. (a) Antibody response (anti-RBD and anti-Trimer IgM, IgA, IgG) in patients who survived and died. (b) An initially significant difference (P = 0.03) between SARS-CoV-2 viral load in patients who survived versus died did not remain significant (Q > 0.05) after adjusting for running multiple tests. (c) Neutralization antibodies in patients who survived and died. Comparisons based on patients that survived and died were made using nonparametric Mann–Whitney U-tests, with adjustments for multiple tests using the false discovery rate.